.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Medtronic
Julphar
UBS
Healthtrust
Argus Health
Farmers Insurance
Queensland Health
Novartis
Express Scripts

Generated: June 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 087487

« Back to Dashboard
NDA 087487 describes MELFIAT-105, which is a drug marketed by Numark and is included in one NDA. Additional details are available on the MELFIAT-105 profile page.

The generic ingredient in MELFIAT-105 is phendimetrazine tartrate. There are five drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.

Summary for NDA: 087487

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE, EXTENDED RELEASE;ORALStrength105MG
Approval Date:Oct 13, 1982TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Novartis
Harvard Business School
AstraZeneca
Argus Health
Express Scripts
US Department of Justice
Queensland Health
Daiichi Sankyo
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot